Anthropic's listing exposes the gap between a stolen stake and a sold one
A near-$40bn paper gain that Sam Bankman-Fried never kept shows how the proceeds of fraud were recycled into creditors' recoveries, just as Anthropic's IPO tests a fragile market.
Watch in 51 seconds
Key points
- The Alameda stake went to creditors in 2024 for about $1.3bn; the listing would value it near $37bn, according to FT calculations.
- The stake was bought with money that was not Bankman-Fried's, so the 'missed windfall' is a counterfactual, not a loss.
- Anthropic's raise of up to $64bn lands amid weak recent IPO performance and high short interest in tech.
A windfall that was never his
The Financial Times reported that Sam Bankman-Fried would have held a stake worth close to $40bn had Anthropic's flotation arrived while he still owned the position. He did not. The stake that Alameda Research Ventures bought for $500mn in 2021 was sold in 2024 for about $1.3bn, and the proceeds went to repay FTX customers and other creditors.
The framing of the story as a missed fortune deserves care. The money behind the investment was drawn from customer deposits, and a New York jury convicted Bankman-Fried of fraud and money laundering over that diversion. A gain on stolen funds would not have been his to keep. The more accurate reading is that a share of the proceeds from a crime ended up, through a court-supervised sale, partly repairing the damage it caused.
That does not make the arithmetic uninteresting. A $500mn cheque for a near-14 per cent holding, at a time when the company was valued at roughly $4bn, is among the most profitable early bets in venture history if the listing prices near the expected $83 a share. The question is what it says about the person who made it, and the honest answer is: less than the headline number suggests.
Skill, luck and someone else's capital
Venture investing rewards a few outsized winners that pay for many failures. Alameda's record in 2021 and 2022 included several such winners, among them a small early cheque into Anysphere and a large position in Robinhood. It also, by the nature of the model, would have included losers that are not part of the story being told. A portfolio viewed only through its best holdings will always look prescient.
There is a sharper point about incentives. An investor spending his own capital bears the downside of a failed bet. Bankman-Fried was spending customer money, so the downside fell on depositors while the upside was meant to accrue to him. That asymmetry encourages exactly the concentrated, high-variance bets that produced both the spectacular wins and the collapse. Ownership of the outcome was never matched by ownership of the risk.
The Anthropic stake also had a specific origin. Bankman-Fried's access ran through the effective altruism network, including the staff of the FTX Future Fund, and the company's focus on AI safety appealed to the movement's concern with long-term risk. Early funding from him helped pay for researchers and the training of the first models. His money was therefore consequential to the company's start, even though the company's current value reflects years of work in which he had no part.
The buyers in 2024 were Mubadala-aligned ATIC Third International Investment, Jane Street, HOF Capital, the Ford Foundation and funds managed by Fidelity. They paid about 2.6 times the original outlay. If the listing prices as expected, their holding would be worth around 74 times Alameda's cost, a return that rewarded patience and a willingness to buy a distressed, contested asset from a bankruptcy estate. The estate itself took a fixed sum and passed on the upside, which is the usual trade-off when administrators prioritise certainty for creditors.
A listing into a nervous market
The timing matters more to markets than the backstory. Anthropic plans to raise up to $64bn, and one weekly outlook has suggested a valuation of up to $1.4tn, below the roughly $1.5tn mentioned elsewhere. The range itself signals that pricing is not settled. The size of the share supply is a concern in its own right, because investors will have to sell something else or add risk to absorb it.
Conditions are not forgiving. Global Eye 24 has reported that the ten largest US IPOs this year have fallen by more than 20 per cent on average, which makes buyers cautious about large new issues. Short interest in the Nasdaq 100 stands at 11 per cent, the highest since 2023, indicating that a meaningful group of investors expects further weakness in technology shares.
Crypto is feeling the same pressure. BitMine chairman Tom Lee has said margin calls from the AI and chip selloff, together with the coming Anthropic listing, may be adding to selling in digital assets. Traders note that Bitcoin also fell sharply before SpaceX's IPO. Whether the link is causal is unclear: investors may be raising cash to subscribe, or simply cutting risk ahead of a heavy calendar.
What to watch
The first signal is where the offering prices relative to the $83 figure and how the book is allocated. A price at the low end, or a reduced raise, would suggest demand is thinner than hoped. The second is first-day and first-week trading: a weak debut in a market already marked down would reinforce the pattern seen in this year's other large listings.
The third is the read-across to crypto and to leveraged technology positions. If selling eases once the shares are allocated, the supply argument gains support. If it continues, the cause is more likely broader risk reduction.
For Bankman-Fried, nothing changes: the stake left his hands years ago, and the money it raised went to people he owed. For everyone else, the listing is the real test. A sovereign-backed fund, a market maker, a foundation and a large asset manager already hold the early shares, and next week the wider market decides what they are worth.
Analysis by the Global Eye 24 desk, with AI assistance. Spot an error? Write to corrections@globaleye24.com.